The loss of phosphorylation of PTPTN11 at Y542, but not at Y580, might suggest the importance of each residue in controlling signalling activation in EML4-ALK+driven NSCLC cell lines. The gene discussed is EML4; the disease is non-small cell lung carcinoma.